Pharma Mar, S.A.

Informe acción BME:PHM

Capitalización de mercado: €600.8m

Dividendos de Pharma Mar

Dividendo controles de criterios 0/6

Pharma Mar es una empresa que paga dividendos con una rentabilidad actual de 2.26%. La fecha del próximo pago es en 14th June, 2024 con una fecha ex dividendo de 12th June, 2024.

Información clave

1.9%

Rentabilidad por dividendo

1,023%

Ratio de pago

Rentabilidad media de la industria1.7%
Próxima fecha de pago de dividendos14 Jun 24
Fecha ex dividendo12 Jun 24
Dividendo por acciónn/a
Beneficios por acción€0.064
Rentabilidad por dividendo prevista a 3 años1.9%

Últimas actualizaciones de dividendos

Recent updates

Pharma Mar, S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 03
Pharma Mar, S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden

Jan 25
Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden

Pharma Mar, S.A. (BME:PHM) Shares Could Be 30% Below Their Intrinsic Value Estimate

Apr 28
Pharma Mar, S.A. (BME:PHM) Shares Could Be 30% Below Their Intrinsic Value Estimate

We Believe That Pharma Mar's (BME:PHM) Weak Earnings Are A Good Indicator Of Underlying Profitability

Mar 08
We Believe That Pharma Mar's (BME:PHM) Weak Earnings Are A Good Indicator Of Underlying Profitability

Analyst Forecasts Just Became More Bearish On Pharma Mar, S.A. (BME:PHM)

Mar 05
Analyst Forecasts Just Became More Bearish On Pharma Mar, S.A. (BME:PHM)

Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet

Feb 09
Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet

We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease

Oct 27
We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease

An Intrinsic Calculation For Pharma Mar, S.A. (BME:PHM) Suggests It's 21% Undervalued

Sep 27
An Intrinsic Calculation For Pharma Mar, S.A. (BME:PHM) Suggests It's 21% Undervalued

Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?

Jul 15
Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?

Growth Investors: Industry Analysts Just Upgraded Their Pharma Mar, S.A. (BME:PHM) Revenue Forecasts By 24%

May 04
Growth Investors: Industry Analysts Just Upgraded Their Pharma Mar, S.A. (BME:PHM) Revenue Forecasts By 24%

Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet

Apr 11
Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet

There Is A Reason Pharma Mar, S.A.'s (BME:PHM) Price Is Undemanding

Mar 16
There Is A Reason Pharma Mar, S.A.'s (BME:PHM) Price Is Undemanding

Is Pharma Mar (BME:PHM) Using Too Much Debt?

Jan 09
Is Pharma Mar (BME:PHM) Using Too Much Debt?

Pharma Mar (BME:PHM) Seems To Use Debt Quite Sensibly

Sep 08
Pharma Mar (BME:PHM) Seems To Use Debt Quite Sensibly

News Flash: Analysts Just Made A Meaningful Upgrade To Their Pharma Mar, S.A. (BME:PHM) Forecasts

Aug 03
News Flash: Analysts Just Made A Meaningful Upgrade To Their Pharma Mar, S.A. (BME:PHM) Forecasts

Here's Why I Think Pharma Mar (BME:PHM) Is An Interesting Stock

May 31
Here's Why I Think Pharma Mar (BME:PHM) Is An Interesting Stock

Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet

May 10
Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet

Is Pharma Mar, S.A. (BME:PHM) Expensive For A Reason? A Look At Its Intrinsic Value

Apr 08
Is Pharma Mar, S.A. (BME:PHM) Expensive For A Reason? A Look At Its Intrinsic Value

Announcing: Pharma Mar (BME:PHM) Stock Increased An Energizing 231% In The Last Five Years

Jan 14
Announcing: Pharma Mar (BME:PHM) Stock Increased An Energizing 231% In The Last Five Years

Is Pharma Mar (BME:PHM) A Risky Investment?

Nov 19
Is Pharma Mar (BME:PHM) A Risky Investment?

Próximo pago de dividendos

HoyMay 15 2024Fecha ex dividendoJun 12 2024Fecha de pago de dividendosJun 14 20242 days desde ex dividendoCompra en los próximos 28 days para recibir el próximo dividendo

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Aunque el pago de dividendos se ha mantenido estable, PHM lleva pagando dividendos menos de 10 años.

Dividendo creciente: El pago de dividendos de PHM ha aumentado, pero la empresa sólo ha pagado dividendos durante 4 años.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Pharma Mar vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de PHM con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (PHM)1.9%
Suelo de mercado 25% (ES)2.2%
Techo de mercado 25% (ES)5.7%
Media de la industria (Biotechs)1.7%
Previsión de analistas en 3 años (PHM)1.9%

Dividendo destacado: El dividendo de PHM(2.26%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado Spanish (2.28%).

Alto dividendo: El (2.45%) del dividendo de PHM es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Spanish (5.77%).


Pago de beneficios a los accionistas

Cobertura de los beneficios: Con su elevado ratio de pago (1023.3%), los pagos de dividendos de PHM no están bien cubiertos por los beneficios.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: PHM está pagando dividendo pero la empresa no tiene flujos de caja libre.


Discover strong dividend paying companies